Fetoscopic tracheal occlusion for treatment of non-isolated congenital diaphragmatic hernia

Research output: Contribution to journalArticlepeer-review

Abstract

Fetoscopic endotracheal occlusion (FETO) is a prenatal treatment that may increase survival in severe congenital diaphragmatic hernia (CDH). In the USA, FETO is offered for isolated severe left-sided CDH in the context of an FDA-approved feasibility study. FETO in non-isolated cases of severe CDH is only performed with a compassionate use exemption from US regulatory bodies. Anomalies frequently associated with CDH include congenital cystic lesions of the lung and cardiac defects. We describe two cases of non-isolated severe left-sided CDH that underwent prenatal FETO, survived after birth and underwent postnatal surgical repair. The potential benefit of FETO in this setting is discussed.

Original languageEnglish (US)
JournalPrenatal Diagnosis
DOIs
StateAccepted/In press - 2017

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'Fetoscopic tracheal occlusion for treatment of non-isolated congenital diaphragmatic hernia'. Together they form a unique fingerprint.

Cite this